Results
|
981.
|
|
|
982.
|
|
|
983.
|
Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles. [electronic resource] by
- Floc'h, Nicolas
- Ashton, Susan
- Taylor, Paula
- Trueman, Dawn
- Harris, Emily
- Odedra, Rajesh
- Maratea, Kim
- Derbyshire, Nicola
- Caddy, Jacqueline
- Jacobs, Vivien N
- Hattersley, Maureen
- Wen, Shenghua
- Curtis, Nicola J
- Pilling, James E
- Pease, Elizabeth J
- Barry, Simon T
Producer: 20180326
In:
Molecular cancer therapeutics vol. 16
Availability: No items available.
|
|
984.
|
|
|
985.
|
|
|
986.
|
|
|
987.
|
|
|
988.
|
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy. [electronic resource] by
- Iankov, I D
- Kurokawa, C B
- D'Assoro, A B
- Ingle, J N
- Domingo-Musibay, E
- Allen, C
- Crosby, C M
- Nair, A A
- Liu, M C
- Aderca, I
- Federspiel, M J
- Galanis, E
Producer: 20160712
In:
Cancer gene therapy vol. 22
Availability: No items available.
|
|
989.
|
|
|
990.
|
|
|
991.
|
Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia. [electronic resource] by
- Mu, Chaofeng
- Wu, Xiaoyan
- Ma, Helen
- Tao, Wenjing
- Zhang, Guodong
- Xia, Xiaojun
- Shen, Jianliang
- Mai, Junhua
- Sun, Tong
- Sun, Xiaoping
- Arlinghaus, Ralph B
- Shen, Haifa
Producer: 20170629
In:
Molecular cancer therapeutics vol. 15
Availability: No items available.
|
|
992.
|
|
|
993.
|
Survivin inhibits anti-growth effect of p53 activated by aurora B. [electronic resource] by
- Jung, Ji-Eun
- Kim, Tae-Kyung
- Lee, Joong-Seob
- Oh, Se-Yeong
- Kwak, Sungwook
- Jin, Xun
- Sohn, Jin-Young
- Song, Min-Keun
- Sohn, Young-Woo
- Lee, Soo-Yeon
- Pian, Xumin
- Lee, Jang-Bo
- Chung, Yong Gu
- Choi, Young Ki
- You, Seungkwon
- Kim, Hyunggee
Producer: 20051212
In:
Biochemical and biophysical research communications vol. 336
Availability: No items available.
|
|
994.
|
|
|
995.
|
|
|
996.
|
|
|
997.
|
|
|
998.
|
Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide. [electronic resource] by
- Santo, Loredana
- Hideshima, Teru
- Cirstea, Diana
- Bandi, Madhavi
- Nelson, Erik A
- Gorgun, Gullu
- Rodig, Scott
- Vallet, Sonia
- Pozzi, Samantha
- Patel, Kishan
- Unitt, Christine
- Squires, Matt
- Hu, Yiguo
- Chauhan, Dharminder
- Mahindra, Anuj
- Munshi, Nikhil C
- Anderson, Kenneth C
- Raje, Noopur
Producer: 20111007
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 17
Availability: No items available.
|
|
999.
|
|
|
1000.
|
|